ReCOGnAIze app to detect mild cognitive impairment and vascular cognitive impairment

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

INTRODUCTION

Mild Cognitive Impairment (MCI) is underdiagnosed due to subtle symptoms. Vascular Cognitive Impairment (VCI), the second leading cause of cognitive impairment, remains underdiagnosed due to varying non-amnestic manifestations. We aimed to develop and validate ReCOGnAIze, a gamified, interpretable digital app to detect MCI and VCI.

METHODS

A multi-phase, cross sectional study in an Asian community cohort with development phase (n=200) and validation with 235 independent participants having comprehensive neuroimaging and neuropsychological data.

RESULTS

In 235 subjects, ReCOGnAIze composite score accurately distinguished MCI from cognitively normal individuals (AUC = 0.90), outperforming the Montreal Cognitive Assessment (AUC = 0.70). For VCI detection, it achieved strong performance (n = 155; Average AUC = 0.85), identifying biomarkers of VCI; response time variability, task efficiency, consistent with known cerebrovascular disease impairments.

DISCUSSION

ReCOGnAIze is a scalable, explainable AI tool that accurately detects MCI and VCI, with interpretable clinical insights.

Article activity feed